A quaternary ammonium compound that is an inhibitor of cholinesterase activity with actions similar to those of neostigmine, but of longer duration. Ambenonium is given by mouth in the treatment of myasthenia gravis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1112)


Symptoms and diagnosis

Symptoms:

    


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.